MaRS Innovation and CDRD Announce Strategic Collaboration
"We are excited about our partnership with the CDRD as it provides an opportunity for the two organizations to augment each other's strengths, and leverage resources to generate attractive packages for potential partners, thereby supporting both of our organizations' mandates of commercializing promising academic research. By entering into this innovative agreement, we believe the commercial potential of select projects in our pipeline will be enhanced," said
"CDRD's collaboration with MaRS Innovation is vital as it allows us to further expand our pipeline of innovative and novel research discoveries beyond British Columbia to include exceptional researchers from the
The first joint project arising out of this collaboration involves technology developed by
"As the inventor, I am looking forward to seeing this innovative technology progress even further by combining the extensive medicinal chemistry work of my lab with the diabetes-specific expertise of
"We believe this technology has the potential to be disease modifying and could create a new paradigm for treating Type 2 Diabetes. This partnership allows us to leverage resources and still focus on our core interests and capabilities. Working with MI and CDRD will provide us with project management oversight, funding support, and access to extensive drug development personnel and infrastructure," said
The Government of Canada's Networks of Centres of Excellence program has recognized both MaRS Innovation and CDRD as "Centres of Excellence in Commercialization in Research (CECR)".
About CDRD
The Centre for Drug Research and Development (CDRD) (www.cdrd.ca) guides and supports early-stage drug development from leading academic and health research institutions to increase the successful commercialization of new therapeutics. CDRD provides drug development expertise and infrastructure to enable researchers to develop promising drug candidates. CDRD's commercial arm, Drug Development Inc (DDI), licenses technologies from affiliated institutions, advances projects by leveraging CDRD's expertise and infrastructure, and establishes working collaborations with other biotech and life sciences companies.
About MaRS Innovation
MaRS Innovation (www.marsinnovation.com) provides an integrated commercialization platform that harnesses the economic potential of the exceptional discovery pipeline of 14 leading
For further information: Jodi Regts, Director, Communications, Centre for Drug Research and Development, (604) 221-7750 x182, [email protected]; Linda Quattrin, Director, Communications, MaRS Discovery District, (416) 673-8104, [email protected]
Share this article